SARS-CoV-2, Hargabka A&B Antigen Combined Detection Kit-EU CE

COVID-19, Hargabka A ama Hargabka B waxay wadaagaan calaamado isku mid ah, taas oo adkeynaysa in la kala saaro saddexda cudur ee fayraska. Cilad-sheegid kala duwan oo loogu talagalay daawaynta ugu wanaagsan ee la beegsanayo waxay u baahan tahay baaritaan wadajir ah si loo ogaado fayrasyada gaarka ah ee cudurka qaba.

Baahiyaha

Ogaanshaha saxda ah ee kala duwanaanshiyaha ayaa muhiim ah si loo hago daaweynta fayraska ee habboon.

Inkasta oo la wadaago calaamado isku mid ah, COVID-19, Flu A iyo Flu B infekshannada waxay u baahan yihiin daaweyn ka hortag ah oo kala duwan.Hargabka waxa lagu daawayn karaa neuraminidase inhibitors iyo COVID-19 daran oo la isticmaalayo remdesivir/sotrovimab.

Natiijooyinka wanaagsan ee hal fayras macnaheedu maaha inaad dadka kale xor ka tahay.Infekshannada wadajirka ah waxay kordhiyaan khatarta cudurrada daran, isbitaal dhigga, dhimashada sababtoo ah saameynaha isku-dhafka ah.

Baaritaanka saxda ah ee baaritaanka multiplex waa muhiim si loo hago daawaynta fayraska ee ku habboon, gaar ahaan cudurrada la isku qaadsiiyo xilliga fayraska neef-mareenka ee ugu sarreeya.

Xalkayaga

Imtixaannada Macro & Micro-TestSARS-CoV-2, Baadhitaanka Isku-dhafka Hargabka A&B Antigen, waxay kala saartaa Hargabka A, Hargabka B iyo COVID-19 oo ay weheliso caabuqyo badan oo suurtagal ah inta lagu jiro xilliga cudurka neef-mareenka;

Tijaabada degdega ah ee caabuqyada badan ee neef-mareenka, oo ay ku jiraan SARS-CoV-2, Flu A, iyo Flu B hal muunad;

Si buuxda u midaysan xariijimo tijaabo ah oo leh hal goob oo kaliya iyo hal muunad ayaa loo baahan yahay si loo kala saaro Covid-19, Flu A iyo Flu B;

4 tillaabo kaliya degdeg ah natiijadu waxay keenaysaa 15-20 daqiiqo oo keliya, taasoo awood u siinaysa go'aan ka gaarista caafimaad degdeg ah.

Noocyo muunado badan: Nasopharyngeal, Oropharyngeal ama sanka;

Heerkulka Kaydinta: 4 -30 ° C;

Shelf Nolosha: 24 bilood.

Xaalado kala duwan sida isbitaalada, rugaha caafimaadka, xarumaha caafimaadka bulshada, farmashiyeyaasha, iwm.

SARS-CoV-2

Hargab A

HargabB

Dareenka

94.36%

94.92%

93.79%

Gaar ahaan

99.81%

99.81%

100.00%

Saxnaanta

98.31%

98.59%

98.73%


Waqtiga boostada: Jan-18-2024